Millennium Management’s Biotech Acquisition Company Unit BIOTU Stock Holding History

Millennium Management’s Portfolio BIOTU Stock Details BIOTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,000	Closed	-$401K	–	7392
2022 Q4	$401K	Hold	40,000	–	–	﹤0.01%	4906
2022 Q3	$397K	Hold	40,000	–	–	﹤0.01%	5147
2022 Q2	$392K	Sell	40,000 -5,000	-11%	-$49.5K	﹤0.01%	5147
2022 Q1	$446K	Hold	45,000	–	–	﹤0.01%	5215
2021 Q4	$455K	Hold	45,000	–	–	﹤0.01%	5136
2021 Q3	$452K	Sell	45,000 -97,280	-68%	-$975K	﹤0.01%	5449
2021 Q2	$1.43M	Hold	142,280	–	–	﹤0.01%	4310
2021 Q1	$1.41M	Buy	+142,280	New	+$1.46M	﹤0.01%	3858

Millennium Management's BIOTU Position: Q1 2023 in Review

Millennium Management sold out of Biotech Acquisition Company Unit (BIOTU) in Q1 2023, closing a stake of 40,000 shares — an estimated $401K sold.

Millennium Management first reported a position in BIOTU in Q1 2021 and held it in 8 quarters. The position peaked at $1.43M in Q2 2021. 0 funds tracked by Wall St. Rank hold BIOTU as of Q1 2023.

Millennium Management reported no remaining Biotech Acquisition Company Unit position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 40,000 Biotech Acquisition Company Unit shares in Q1 2023, an estimated $401K.
Millennium Management first reported a position in Biotech Acquisition Company Unit in Q1 2021 and held it in 8 quarters.
Millennium Management's Biotech Acquisition Company Unit position peaked at $1.43M in Q2 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Unit as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.